Medical marijuana for anxiety and depression - what we really know

This is one of the most complex topics in medical cannabis. Medical marijuana can genuinely reduce anxiety in some patients - but in others it can make it worse. It may improve functioning in depression secondary to pain or insomnia - but it is not an antidepressant and cannot replace psychotherapy or pharmacotherapy. The difference between relief and deterioration lies in the preparation, the dose, and the individual patient's medical history.

Below is an honest summary of what the research says (and does not say), for whom cannabis may be helpful in the context of anxiety and depression, and when it is better to choose a different path.

Anxiety disorders and depression are distinct conditions, though they often co-occur. Anxiety is an overactivated threat-response system - chronically elevated cortisol, an accelerated heart rate, difficulty winding down. Depression is primarily a deficit of motivation, mood, and energy, linked to dopaminergic and serotonergic dysregulation.

Cannabis acts on the endocannabinoid system, which is involved in regulating both conditions - but the mechanisms differ. CBD has well-documented anxiolytic properties and modulates serotonin receptors. THC at low doses can be relaxing; at high doses it paradoxically amplifies anxiety. In depression, the role of cannabis is considerably more limited and less well-documented.

This distinction matters: the evidence for cannabis is stronger for anxiety than for depression. If your primary problem is depression, a doctor will likely consider cannabis only when it is accompanied by other symptoms - insomnia, pain, situational anxiety - where it may genuinely help.

THC is a dose-dependent substance in a way that can be surprising: the same molecule can both reduce anxiety and trigger it. This property, known as bidirectionality or the biphasic effect, has direct implications for treatment.

At low doses (on the order of a few milligrams) THC can produce relaxation, reduced tension, and improved mood. At medium and high doses - particularly in people without tolerance - it frequently causes anxiety, tachycardia, and in sensitive individuals even episodes of panic. A study published in JAMA (Zamarripa et al., 2024) found that combining THC with a high dose of CBD paradoxically increased feelings of paranoia and anxiety in participants - indicating that the simple rule "CBD cancels out THC" does not always hold.

For this reason, in patients with anxiety disorders doctors typically reach for CBD-dominant preparations (e.g. a CBD:THC ratio of 20:1 or higher) or very low doses of THC introduced gradually. The preparation profile is not a preference - it is a safety requirement. You can read more about choosing the right ratio in the article on THC:CBD ratios in therapy.

For CBD in anxiety disorders we have the most promising, though still limited, evidence. A systematic review published in 2024 in PMC (Botsford et al.) covered more than a dozen randomized clinical trials. The results are mixed: a 300 mg dose of CBD showed efficacy for public-speaking anxiety in several studies, but the same dose provided no relief for other types of anxiety (trauma, paranoia). Importantly, higher doses of CBD - 600 mg - worsened symptoms in some participants. Researchers note that CBD exhibits an inverted-U dose-response curve: there is an optimal dose, above and below which effects diminish or reverse.

For THC in anxiety the evidence is weaker and more ambiguous. Observational data from the Strainprint app showed short-term anxiety relief in 93% of sessions, but prospective studies do not confirm the durability of these effects. A meta-analysis of 24 longitudinal studies from 2021 found only marginally elevated risk of anxiety disorders among cannabis users (odds ratio 1.25) - and the effect disappeared when the analysis was restricted to high-quality studies.

For depression the picture is even more cautious. A randomized trial conducted in Massachusetts (2022) showed no significant improvement in depression scores after 12 weeks of access to medical marijuana (difference -0.5, p=0.3). A 2025 meta-analysis confirmed that cannabis users have a higher risk of clinical depression than non-users - though this relationship is complex and does not imply simple causality.

In summary: there is some evidence that CBD may reduce situational anxiety in some patients. For depression as a primary indication, strong RCT evidence is lacking. That is an honest answer - and any doctor prescribing cannabis should tell you exactly that.

Despite the limited evidence base, there are situations in which cannabis treatment makes sense for these problems:

This section must not be skipped. For anxiety and depression there are groups for whom cannabis - and in particular THC-containing preparations - is potentially harmful:

If you recognize yourself in any of the above points, tell your doctor during your appointment. The medical history is not a formality. Its purpose is precisely to identify these risks before therapy begins.

If you have obtained a preparation and feel the effect is too intense or is causing anxiety, read the article on what to do when THC feels too strong.

If a doctor decides that cannabis therapy makes sense in your case, one firm rule applies: start low, go slow - begin with the lowest possible dose and increase very gradually.

For anxiety, the typical starting point is a CBD-dominant preparation (e.g. CBD oil 20:1 or high-CBD flower) at a dose close to 5-10 mg of CBD per day. When insomnia accompanies anxiety, doctors sometimes add a micro-dose of THC in the evening - on the order of 1-2 mg. For context: doses used in clinical trials on CBD are typically 150-600 mg per day - figures that do not apply to most prescription preparations.

More about the dosing framework is available in the article on dosing medical marijuana and on microdosing, which can be particularly useful for anxiety.

The form of administration matters: inhalation produces a rapid effect but is harder to dose precisely - the risk of exceeding the optimal dose is greater. Oil or capsules act more slowly but provide a more reproducible dose. Details: forms of administration of medical marijuana.

This is a point the doctors at this clinic state plainly: medical marijuana does not treat the underlying causes of anxiety or depression. It may relieve symptoms, improve sleep, and reduce somatic tension - and in doing so create better conditions for therapeutic work. But symptom relief alone is not therapy.

Cognitive behavioral therapy (CBT) has the strongest evidence for anxiety disorders and depression of any psychological intervention. Antidepressants (SSRIs/SNRIs) have a solid evidence base in moderate and severe depression. Cannabis is not in that league.

The best possible scenario is combined treatment: a psychiatrist or psychotherapist plus a cannabis medicine doctor who communicate with each other. Do not discontinue psychiatric medications on your own. Decisions about changes to pharmacotherapy belong to your treating physician.

An important financial note: the cost of cannabis therapy is not just the prescription. If you want a full picture of the expenses, check the cost of medical marijuana therapy in 2026.

The qualification appointment at Cannabis Medic lasts 20-30 minutes and costs 169 PLN. It is in-person - in Krakow, Bydgoszcz, Torun, or Kielce. An electronic prescription (eRecepta) is issued during the visit.

For anxiety and depression the doctor will ask about: your psychiatric diagnosis (if any), medications currently taken, history of panic attacks or psychotic episodes, and any previous experience with cannabis. It is worth bringing psychiatric treatment records if you have them - they speed up the history-taking and improve the choice of preparation.

If you are unsure whether you qualify for treatment, or you want to find out what the whole procedure involves, read the article on how to obtain a medical marijuana prescription.

Does medical marijuana treat depression? Not directly. It may relieve symptoms that accompany depression - insomnia, pain, anxiety - and thereby improve daily functioning. As a standalone treatment for depression it lacks sufficient evidence from clinical trials.

Is CBD safe for panic disorder? It depends on the preparation and dose. CBD on its own has anxiolytic properties, but in panic disorder even small amounts of THC can trigger an attack. Selection by a doctor is essential - no self-treatment.

Can I combine cannabis with antidepressants? Only under medical supervision. CBD can inhibit liver enzymes responsible for metabolizing many drugs (CYP450), which alters their blood concentration. With SSRIs/SNRIs there is no absolute prohibition, but monitoring is required.

How long before I feel an effect? With oils and capsules: from a few days to 2-3 weeks of regular use. With inhalation: within minutes. Effects on mood and anxiety are usually noticeable after 2-4 weeks of regular therapy.

Is marijuana psychologically addictive? Yes, psychological dependence is possible, though less common than with alcohol or benzodiazepines. It is estimated to affect around 9% of regular users. In psychiatric treatment, the risk of dependence is one of the factors the doctor takes into account.

What if THC worsens my anxiety? Stop using it and do not panic - the effect usually wears off within 1-2 hours. Contact your doctor before the next use. More practical guidance on different forms of administration of preparations.